Symposium topic
Today’s humanitarian challenges require combining scientific innovation and industrial expertise together with emergency response capacity. Since 1982, Humanity & Inclusion (HI) has provided P&O care to populations affected by conflict and disaster, progressively integrating digital fabrication technologies. Its long-standing collaboration with PROTEOR, a French orthopedic manufacturer forged across major crises in Armenia, Balkans, Pakistan, Haiti, and Middle East, its academic partnership with INSA Lyon, formalized through the Innovation for Humanity Alliance (2021), have generated a unique tri-actor ecosystem. This symposium examines the added value of this academic–industrial–humanitarian collaboration in advancing fused filament fabrication (FFF) (3D printing) to better meet the needs of P&O care in low-resource settings.
Underpinning science and theory
The study's evidence includes a multi-country comparative study of FFF transtibial prosthesis fabrication, a randomized trial on additively manufactured thermoplastic devices, a social-impact assessment of 3D-printed P&O in West Africa, and INSA doctoral research on recycled materials applied to humanitarian additive manufacturing. HI received the EU Horizon Prize for Affordable High-Tech Humanitarian Aid (2020).
Relevance for the ISPO World Congress
This symposium directly addresses the congress theme “A World Connected: Advancing Assistive Technologies for Global Equity.” This three-way collaboration demonstrates how academic, industrial, and humanitarian partnership can generate evidence, drive innovation, and expand access to FFF-based P&O care in low-resource and crisis-affected settings.
Perspectives
Three complementary perspectives are presented: humanitarian implementation (strategy, clinical outcomes, circular economy approaches), industrial innovation (product adaptation, FFF co-development, partnership governance), and academic research (materials science, fabrication robustness, sustainable local materials). Shared challenges, unexpected benefits, and future opportunities for collaboration are also discussed.
Learning objectives
At end of this session, participants will be able to:
• Describe the governance, co-development model of a tri-actor academic-industrial-humanitarian partnership for FFF-based P&O care, including roles and contributions of each actor.
• Critically appraise multi-country evidence on fused filament fabrication outcomes in humanitarian P&O programs, including quality, cost-effectiveness, clinical acceptance.
• Identify practical enablers, barriers including material constraints, regulatory environments, timeframe mismatches for implementing FFF, circular economy approaches in low-resource P&O programs.
• Apply the tri-actor collaboration model to their own organizational or research context, identify potential entry points for academic, industrial, or humanitarian partnership.